---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-078462"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2023-07-06T23:59:59+00:00"
generated_at: "2026-06-13T12:07:44.072504+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition raises additional $22.3M in PIPE for TriSalus merger; amends merger agreement

## Summary
- Entered into subscription agreements for 2,229,500 shares of Series A Preferred at $10/share, aggregate $22,295,000.
- Combined with prior $17.855M, total PIPE proceeds of approximately $40.15M.
- Backstop Letter Agreement with Sponsor terminated as $2M commitment fulfilled by members via additional subscriptions.
- Third Amendment to Merger Agreement updates form of bylaws for post-merger TriSalus Life Sciences.

## SEC filing metadata
- accession: 0001104659-23-078462
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2023-07-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465923078462/0001104659-23-078462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465923078462/tm2320024d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-078462
- JSON: https://secwatch.observer/filing/0001104659-23-078462.json
- Plain text: https://secwatch.observer/filing/0001104659-23-078462.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.